Page last updated: 2024-10-24

positive regulation of cardiac muscle hypertrophy in response to stress

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of cardiac muscle hypertrophy in response to stress. [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:19287093]

Positive regulation of cardiac muscle hypertrophy in response to stress is a complex process that involves a variety of signaling pathways and transcription factors. The process is initiated by mechanical or biochemical stressors such as increased blood pressure, increased blood volume, or elevated levels of hormones like angiotensin II. These stressors activate signaling pathways such as the MAPK, PI3K/Akt, and calcineurin pathways. These pathways converge on transcription factors like NFAT, MEF2, and GATA4 which regulate the expression of genes involved in hypertrophy, including genes encoding contractile proteins, sarcomeric proteins, and structural proteins. The upregulation of these genes leads to an increase in the size and strength of cardiac myocytes, resulting in hypertrophy. However, chronic or excessive hypertrophy can lead to maladaptive remodeling of the heart, ultimately contributing to heart failure. The precise mechanisms by which stress-induced signaling pathways activate transcription factors and regulate gene expression in cardiac myocytes are still being elucidated, but involve complex interactions between these signaling pathways and various epigenetic regulators, including histone modifications and microRNAs. Therefore, the process of positive regulation of cardiac muscle hypertrophy in response to stress involves a multifaceted interplay of signaling pathways, transcription factors, and epigenetic mechanisms.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Short transient receptor potential channel 3A short transient receptor potential cation channel TRPC3 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q13507]Homo sapiens (human)
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformA protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
ym 58483
clemizoleclemizole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a pyrrolidin-1-ylmethyl and a 4-chlorobenzyl groups at positions 2 and 1 respectively.

clemizole: was heading 1966-94 (see under BENZIMIDAZOLES 1966-90); use BENZIMIDAZOLES to search CLEMIZOLE 1966-94; a histamine H1- blocker used to treat allergies
benzimidazoles;
monochlorobenzenes;
pyrrolidines
histamine antagonist
N-butyl-1H-benzimidazol-2-aminebenzimidazoles
tacrolimustacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
macrolide lactambacterial metabolite;
immunosuppressive agent
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
4-[3-(4-fluorophenyl)-2-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]-1-piperidinecarboxylic acid ethyl esterpyrazoles;
ring assembly
ethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1h-pyrazole-4-carboxylateethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate: structure in first source